Abstract
The cytotoxic and biochemical activity of the pyrrolopyrimidine antibiotic, sangivamycin, was examined in a human colon carcinoma in tissue culture. Logarithmically growing cells were more sensitive than early plateau-phase cells to the lethal effects of the drug as determined by colony formation in soft agar. Cell lethality in both log- and plateau-phase cells became more pronounced when drug exposure time was increased from 2 hr to 24-48 hr. Reduced cell viability correlated with the inhibition of total RNA synthesis after 2 hr of drug exposure, and with reduced DNA synthesis and incorporation of drug into DNA and RNA after 24-48 hr of drug exposure. Fractionation of total RNA into non-poly(A)-containing and poly(A)-containing RNA indicated that inhibition of the synthesis of both RNA species occurred after 24 hr of exposure of log-phase cells to sangivamycin. Neither RNA fraction was affected in plateau-phase cells after 48 hr of drug exposure. In contrast, a close correlation was found between the incorporation of [3H]sangivamycin into poly(A)RNA and cell lethality after 24-48 hr of exposure of both log- and plateau-phase cells to sangivamycin. These results show that a human colon carcinoma is responsive to sangivamycin following prolonged drug-exposure intervals and that the associated cytotoxicity correlates closely with the incorporation of drug into mRNA, as well as inhibition of DNA synthesis.
- Copyright © 1981 by The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|